CN Bio raises $21 million to scale up organ-on-a-chip technology
Apr 23, 2024 · CN Bio has raised $21 million in Series B financing to meet increasing demand for its organ-on-a-chip (OOC) solutions.
Biopharmaceutical Manufacturing, Upstream, Downstream …
3 days ago · News on the biopharmaceutical manufacturing industry, focusing on biologics, technology, upstream/downstream processing, cell culture and regulations
Amgen: Phase 2 results for GLP-1-GIP weight loss drug
Nov 28, 2024 · MariTide is being studied for the treatment of obesity and Type 2 diabetes and demonstrated weight loss at 52 weeks.
Trends in biosimilars: Regulatory approvals in 2024
Jul 24, 2024 · Demand for biosimilars is booming, with no hints of slowing down as the number of biosimilars getting approved keeps growing. Here are all the biosimilars that have received …
How will the Biosecure Act impact the pharma industry?
Oct 8, 2024 · But what does the Act mean for the biotech and pharma industry and how can companies best prepare for any impacts on future business? The Biosecure Act was first …
Automation in cell therapy manufacturing and CAR-T therapy: Cytiva
Oct 8, 2024 · Cytiva recently launched the Sefia cell therapy manufacturing platform, which was developed in collaboration with Kite Pharma, to automate the cell therapy workflow. Sefia uses …
Anticipation mounts as Insmed's bronchiectasis therapy nears …
May 13, 2024 · The therapy has sparked significant anticipation within the medical community ahead of its phase 3 outcomes. A positive outcome from this study could lay the groundwork …
Regenxbio and Nippon Shinyaku collaborate on gene therapies for ...
Jan 14, 2025 · The US gene therapy company Regenxbio and the Japanese firm Nippon Shinyaku have joined forces to boost the development and commercialization of Regenxbio’s …
Aditum Bio and Leads Biolabs join forces to fight autoimmune …
Nov 7, 2024 · The U.S. company Aditum Bio and Chinese company Leads Biolabs today announced that they have founded Oblenio Bio, a new company that will develop a potentially …
FDA approves Astellas’ Vyloy cancer drug & Roche diagnostic test
Oct 22, 2024 · The FDA has simultaneously granted approval to Astellas’ cancer drug Vyloy and to a companion diagnostic test developed by Roche.